INSIGHTS ON DRUG DEVELOPMENT
-
Coordinated Development As An Execution Framework
See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.
-
Simplify Cell Line Development
A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.
-
How AI Is Reshaping Pharmacovigilance: Key Takeaways From The New CIOMS Report
Deploying AI in pharmacovigilance requires risk-based oversight, human accountability, transparent governance, and representative performance testing.
-
Development Of Scalable Purification For Biotherapeutic Peptides
Discover key strategies for reversed-phase isolation of biotherapeutic peptides, as well as learn about method development, scale-up techniques, and RP/MS analysis to enhance purification workflows.
-
Automated Bioburden Testing Solution11/7/2025
Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.
-
SEC HPLC Columns With Ultra Inert Technology8/18/2026
See how reducing secondary interactions in size exclusion chromatography gives scientists greater freedom to optimize conditions around their samples, helping simplify method development.
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Leveraging Early Insights To Accelerate The Oral Drug Development Cycle8/31/2026
Consider how the following early development insights can help you navigate complex oral drug development and move your program forward with greater confidence.
-
Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering7/31/2025
Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.
DRUG DEVELOPMENT SOLUTIONS
-
Find the missing links
The modular DMi8 inverted microscope is the heart of the DMi8 S platform solution. For routine to live cell research, the DMi8 S platform is a complete solution. Whether you need to precisely follow the development of a single cell in a dish, screen through multiple assays, obtain single molecule resolution, or tease out behaviors of complex processes, a DMi8 S system will enable you to see more, see faster, and find the hidden.
- See more – Increase your viewing area up to 10,000x
- See faster – Experiments up to 5x faster
- See the hidden – Activate, ablate, and bleach within one experiment
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
-
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.